Surveys after genetic risk results for certain breast cancer genes
Part of Cancer, Genetic & congenital, Women’s health & pregnancy clinical trials.
This study asks women to complete surveys after learning their genetic risk results for certain breast cancer–related gene changes. It helps researchers understand how people respond and what they think or feel after getting these results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 25 or older (or age 30 or older for some gene results)
- You have a confirmed harmful (pathogenic) gene change from genetic testing (BRCA1, BRCA2, or specific other genes)
- You have not had breast cancer personally
- You can read and answer surveys in English
- You have not had a preventive (prophylactic) mastectomy
- You can follow the study steps and complete the surveys
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how men with a BRCA1/2 gene change make decisions about their health and prostate cancer risk. Participants will fill out surveys to help researchers understand these choices.
This study follows people who carry a harmful BRCA1 or BRCA2 gene mutation, whether or not they currently have breast or ovarian cancer. The goal is to better understand cancer risk over time and how being a carrier may affect screening and care.
This trial studies what people and families think and understand about genetic test results, especially when results suggest a higher risk for disease. It may also include interviews and follow-up, and in some cases additional family testing if it fits the study’s goals.
This study tests a new ultra-rapid genetic test for BRCA1/2 mutations in people recently diagnosed with breast cancer. It aims to see if the faster result helps doctors and patients make treatment decisions sooner.
This study looks at the genetics of breast cancer by collecting DNA from a saliva sample and asking you to fill out a health survey online. It's open to anyone in the U.S. who is 18 or older and can complete the study materials in English.
This study creates a platform for women who carry a BRCA1 or BRCA2 gene mutation to be followed over time. It aims to better understand and manage cancer risks associated with these mutations.
Hear when a new Genetic Testing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.